Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Combinatorial Anti-Tumor Activity in Animal Models of a Novel CD123 x CD3 Bispecific Dart® Molecule (MGD024) with Cytarabine, Venetoclax or Azacitidine Supports Combination Therapy in Acute Myeloid Leukemia

Ralph F. Alderson, Ling Huang, Xiaoyu Zhang, Haiquan Li, Thomas Kaufman, Gundo Diedrich, Paul Moore, Ezio Bonvini

Blood (2021) 138 (Supplement 1): 1165.

https://doi.org/10.1182/blood-2021-153192

Published: 2021

Journal Articles

Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas

Ling Huang, MD, Xinmiao Jiang, MD, Wenyu Li, PhD, Hanguo Guo, Xiaojuan Wei, Sichu Liu, MD, Feili Chen, Zhanli Liang

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-142364

Published: 2020

Journal Articles

Ctdna Monitoring in Predicting Relapse of Primary Mediastinal B-Cell Lymphoma

Diwen Pang, Xinmiao Jiang, MD, Ling Huang, MD, Yan Teng, Sichu Liu, MD, Feili Chen, Xiaojuan Wei, Hanguo Guo, Wenyu Li, PhD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-142349

Published: 2020

Journal Articles

Acquired Resistance to JAK Inhibitors in Calr-Mutated Myeloproliferative Neoplasms

Ken-Hong Lim, MD, Yu-Cheng Chang, MD, Yi-Hao Chiang, MD, Huan-Chau Lin, MD, Ling Huang, MSc, Wei-Ting Wang, MSc, Ying-Wen Su, MD, PhD, Ming-Chih Chang, MD, Yi-Fang Chang, MD PhD, Caleb Gon-Shen Chen, MD PhD

Blood (2019) 134 (Supplement_1): 2970.

https://doi.org/10.1182/blood-2019-124420

Published: 2019

Journal Articles

The Unfolded Protein Response Causes Prothrombotic Transformation of Pancreatic Cancer Linking Tumor Progression with Cancer-Associated Thrombosis

Oluwatoyosi Muse, PhD, Rushad Patell, MD, Christian Peters, PhD, Sol Schulman, MD PhD, Emale Darzi, MS, Calvin Schuster, BA, Ling Huang, PhD, Shibani Mukherjee, PhD, Senthil Muthuswamy, PhD, Jeffrey I. Zwicker, MD, Robert C. Flaumenhaft, MD PhD

Blood (2019) 134 (Supplement_1): 632.

https://doi.org/10.1182/blood-2019-123544

Published: 2019

Journal Articles

Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population

Wenyu Li, MD PhD, Ling Huang, MD, Xinmiao Jiang, MD, Xiaojuan Wei, Hanguo Guo, Liu Sichu, MD, Chen Feili, MD, Zhanli Liang

Blood (2019) 134 (Supplement_1): 5271.

https://doi.org/10.1182/blood-2019-129552

Published: 2019

Journal Articles

TRAF1-ALK Fusion Predicts Poor Prognosis for ALK Positive Anaplastic Large Cell Lymphoma Patients with Chemotherapy and ALK Inhibitor

Ling Huang, MD, Xinmiao Jiang, MD, Hanguo Guo, Liu Sichu, MD, Xiaojuan Wei, Chen Feili, MD, Zhanli Liang, Wenyu Li, MD PhD

Blood (2019) 134 (Supplement_1): 5224.

https://doi.org/10.1182/blood-2019-126541

Published: 2019

Journal Articles

Comprehensive Genomic Profiling of Adult T-Cell Lymphoblastic Lymphoma in Chinese Patients

Feili Chen, Hanguo Guo, Ling Huang, MD, Xinmiao Jiang, MD, Xiaojuan Wei, Wenyu Li, MD PhD

Blood (2019) 134 (Supplement_1): 5039.

https://doi.org/10.1182/blood-2019-126624

Published: 2019

Journal Articles

Distinct Microrna Profiles in Patients with Essential Thrombocythemia: Clinical and Prognostic Correlation

Yi-Hao Chiang, MD, Yu-Cheng Chang, MD, Huan-Chau Lin, MD, Ling Huang, MSc, Chun-Chia Cheng, PhD, Nai-Wen Su, MD, Caleb Gon-Shen Chen, MD PhD, Johnson Lin, MD, Ruey-Kuen Hsieh, MD, Ming-Chih Chang, MD, Yi-Fang Chang, MD PhD, Wei-Ming Chen, Shih-Ting Kang, Yu-Shan Huang, Jian-Yi Lin, Tiffany Wang, Ken-Hong Lim, MD

Blood (2018) 132 (Supplement 1): 3045.

https://doi.org/10.1182/blood-2018-99-114921

Published: 2018

Journal Articles

A Next-Generation Fc-Bearing CD3-Engaging Bispecific DART ® Platform with Extended Pharmacokinetic and Expanded Pharmacologic Window: Characterization As CD123 x CD3 and CD19 x CD3 DART Molecules

Ezio Bonvini, MD, Ross La Motte-Mohs, PhD, Ling Huang, Chia-Ying Kao Lam, PhD, Thomas Kaufman, Liqin Liu, PhD, Ralph F. Alderson, PhD, Kurt Stahl, Jennifer G. Brown, PhD, Hua Li, Sharad Sharma, PhD, James Tamura, PhD, Syd Johnson, PhD, Paul Moore, PhD

Blood (2018) 132 (Supplement 1): 5230.

https://doi.org/10.1182/blood-2018-99-116264

Published: 2018

Journal Articles

Next Generation Sequencing Highlights the Role of Cell Cycle and Apoptosis Dysregulation and Hepatitis B Infection in Refractory Diffuse Large B Cell Lymphoma

Wenyu Li, PhD, Xinmiao Jiang, Hanguo Guo, Xiaojuan Wei, Feili Chen, Sichu Liu, MD, Ling Huang, MD, Zhanli Liang

Blood (2017) 130 (Supplement 1): 5131.

https://doi.org/10.1182/blood.V130.Suppl_1.5131.5131

Published: 2017

Journal Articles

Overexpression of Calr Mutants Perturbs Developmental Hematopoiesis in Zebrafish Embryos

Ken-Hong Lim, MD, Yu-Cheng Chang, MD, Yi-Hao Chiang, MD, Huan-Chau Lin, MD, Chiao-Yi Chang, MSc, Ching-Sung Lin, MSc, Ling Huang, MSc, Wei-Ting Wang, MSc, Caleb Gon-Shen Chen, MD PhD, Wen-Chien Chou, MD PhD, Yuan-Yeh Kuo, PhD

Blood (2016) 128 (22): 4282.

https://doi.org/10.1182/blood.V128.22.4282.4282

Published: 2016

Journal Articles

B Cell Immune Profiles in Essential Thrombocythemia with Calr Mutations: Clinical and Molecular Correlates

Yu-Cheng Chang, MD, Ken-Hong Lim, MD, Huan-Chau Lin, MD, Yi-Hao Chiang, MD, Ling Huang, MSc, Chen-Wei Kao, Chiao-Yi Chang, MSc, Ching-Sung Lin, MSc, Nai-Wen Su, MD, Johnson Lin, MD MPH, Ruey-Kuen Hsieh, MD, Ming-Chih Chang, MD, Yi-Fang Chang, MD PhD, Caleb Gon-Shen Chen, MD PhD, Yuan-Yeh Kuo, PhD, Wen-Chien Chou, MD PhD

Blood (2015) 126 (23): 1610.

https://doi.org/10.1182/blood.V126.23.1610.1610

Published: 2015

Journal Articles

Antiviral Efficacy Analysis of Telbivudine Concurrent with the First Cycle of Chemotherapy in HBsAg-Positive Lymphoma Patients

Wenyu Li, Doctor of MDcine, Ling Huang, Master of MDcine, Hanguo Guo, undergraduate, Xiaojuan Wei, undergraduate, Zhanli Liang, undergraduate

Blood (2014) 124 (21): 4437.

https://doi.org/10.1182/blood.V124.21.4437.4437

Published: 2014

Journal Articles

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

Paul A. Moore, Wenjun Zhang, G. Jonah Rainey, Steve Burke, Hua Li, Ling Huang, Sergey Gorlatov, Maria Concetta Veri, Sudeepta Aggarwal, Yinhua Yang, Kalpana Shah, Linda Jin, Sunan Zhang, Leilei He, Tengfei Zhang, Valentina Ciccarone, Scott Koenig, Ezio Bonvini, Syd Johnson

Blood (2011) 117 (17): 4542–4551.

https://doi.org/10.1182/blood-2010-09-306449

Published: 2011

Includes: Supplemental data

Journal Articles

An Fc-Optimized Monoclonal Antibody Against CD32B, the Human Inhibitory Fc- γ Receptor IIB, in the Immunotherapy of B-Cell Malignanacy.

Jeffrey B. Stavenhagen, PhD, Sergey Gorlatov, Ph.D., Nadine Tuaillon, Ph.D., Christopher T. Rankin, Ph.D., Maria-Concetta Veri, Ph.D., David Inzunza, M.D., Stephen Burke, Ling Huang, Hua Li, Shannon Thomas, Syd Johnson, Ph.D., Jeffrey Ravetch, M.D., Ph.D., Scott Koenig, M.D., Ph.D., Ezio Bonvini, MD

Blood (2006) 108 (11): 2529.

https://doi.org/10.1182/blood.V108.11.2529.2529

Published: 2006

Journal Articles

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

Christopher T. Rankin, Maria-Concetta Veri, Sergey Gorlatov, Nadine Tuaillon, Steve Burke, Ling Huang, H. David Inzunza, Hua Li, Shannon Thomas, Syd Johnson, Jeffrey Stavenhagen, Scott Koenig, Ezio Bonvini

Blood (2006) 108 (7): 2384–2391.

https://doi.org/10.1182/blood-2006-05-020602

Published: 2006

Includes: Supplemental data

Journal Articles

In Vitro Hematopoietic and Endothelial Cell Development From Cells Expressing TEK Receptor in Murine Aorta-Gonad-Mesonephros Region

Isao Hamaguchi, Xu-Ling Huang, Nobuyuki Takakura, Jun-ichi Tada, Yuji Yamaguchi, Hiroaki Kodama, Toshio Suda

Blood (1999) 93 (5): 1549–1556.

https://doi.org/10.1182/blood.V93.5.1549

Published: 1999

NARROW

Combinatorial Anti-Tumor Activity in Animal Models of a Novel CD123 x CD3 Bispecific Dart® Molecule (MGD024) with Cytarabine, Venetoclax or Azacitidine Supports Combination Therapy in Acute Myeloid Leukemia

Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas

Ctdna Monitoring in Predicting Relapse of Primary Mediastinal B-Cell Lymphoma

Acquired Resistance to JAK Inhibitors in Calr-Mutated Myeloproliferative Neoplasms

The Unfolded Protein Response Causes Prothrombotic Transformation of Pancreatic Cancer Linking Tumor Progression with Cancer-Associated Thrombosis

Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population

TRAF1-ALK Fusion Predicts Poor Prognosis for ALK Positive Anaplastic Large Cell Lymphoma Patients with Chemotherapy and ALK Inhibitor

Comprehensive Genomic Profiling of Adult T-Cell Lymphoblastic Lymphoma in Chinese Patients

Distinct Microrna Profiles in Patients with Essential Thrombocythemia: Clinical and Prognostic Correlation

A Next-Generation Fc-Bearing CD3-Engaging Bispecific DART ® Platform with Extended Pharmacokinetic and Expanded Pharmacologic Window: Characterization As CD123 x CD3 and CD19 x CD3 DART Molecules

Next Generation Sequencing Highlights the Role of Cell Cycle and Apoptosis Dysregulation and Hepatitis B Infection in Refractory Diffuse Large B Cell Lymphoma

Overexpression of Calr Mutants Perturbs Developmental Hematopoiesis in Zebrafish Embryos

B Cell Immune Profiles in Essential Thrombocythemia with Calr Mutations: Clinical and Molecular Correlates

Antiviral Efficacy Analysis of Telbivudine Concurrent with the First Cycle of Chemotherapy in HBsAg-Positive Lymphoma Patients

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

An Fc-Optimized Monoclonal Antibody Against CD32B, the Human Inhibitory Fc- γ Receptor IIB, in the Immunotherapy of B-Cell Malignanacy.

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

In Vitro Hematopoietic and Endothelial Cell Development From Cells Expressing TEK Receptor in Murine Aorta-Gonad-Mesonephros Region

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only